Literature DB >> 29878036

Predicting Premorbid Scores on the Repeatable Battery for the Assessment of Neuropsychological Status and their Validation in an Elderly Sample.

Kevin Duff1, Bonnie C A Dalley1, Kayla R Suhrie1, Dustin B Hammers1.   

Abstract

OBJECTIVE: Assessing cognitive change during a single visit requires the comparison of estimated premorbid abilities and current neuropsychological functioning. Although premorbid intellect has been widely examined, premorbid expectations for other cognitive abilities have received less attention. The current study sought to develop and validate premorbid estimates for the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
METHOD: Using demographic variables and an estimate of premorbid intellect, premorbid performance on the RBANS was predicted in a sample of 143 community-dwelling, cognitively intact older adults.
RESULTS: On all six Indexes of the RBANS, premorbid intellect was the best predictor of current cognitive functioning, with gender adding to one of the prediction models (R2 = 0.04-0.16, ps < .02). These prediction formulae were then applied to a sample of 122 individuals with amnestic Mild Cognitive Impairment to look for discrepancies between premorbid and current RBANS scores. Despite minimal differences between premorbid and current RBANS scores in the intact sample, large, and statistically significant differences were observed in the impaired sample, especially on the Immediate Memory Index (discrepancy = -29.00, p < .001), Delayed Memory Index (discrepancy = -32.28, p < .001), and Total Scale score (discrepancy = -25.58, p < .001).
CONCLUSION: Although validation in larger samples is needed, the current estimates of premorbid RBANS abilities may aid clinicians in determining change across time.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Elderly/geriatrics/aging; Learning and memory; Mild cognitive impairment

Mesh:

Year:  2019        PMID: 29878036     DOI: 10.1093/arclin/acy050

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  1 in total

1.  Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation.

Authors:  Georg Berding; Karin Weissenborn; Meike Dirks; Ralph Buchert; Ann-Katrin Wirries; Henning Pflugrad; Gerrit M Grosse; Carlotta Petrusch; Christian Schütze; Florian Wilke; Martin Mamach; Linda Hamann; Laura B N Langer; Xiao-Qi Ding; Hannelore Barg-Hock; Jürgen Klempnauer; Christian H Wetzel; Mario Lukacevic; Eike Janssen; Mariella Kessler; Frank M Bengel; Lilli Geworski; Rainer Rupprecht; Tobias L Ross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-12       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.